ENDOLOGIX INC's ticker is and the CUSIP is 29266SAA4. A total of 19 filers reported holding ENDOLOGIX INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,279,000 | -26.6% | 1,394,000 | -41.8% | 0.09% | -19.6% |
| Q1 2016 | $1,742,000 | -13.5% | 2,394,000 | 0.0% | 0.11% | -10.8% |
| Q4 2015 | $2,014,000 | -49.2% | 2,394,000 | -45.5% | 0.12% | -48.5% |
| Q3 2015 | $3,964,000 | +11.6% | 4,394,000 | +20.4% | 0.23% | +40.4% |
| Q2 2015 | $3,553,000 | +3.1% | 3,648,000 | +7.3% | 0.17% | +0.6% |
| Q4 2013 | $3,445,000 | – | 3,400,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 51,117,000 | $46,140,000 | 1.90% |
| PFM Health Sciences, LP | 6,445,000 | $5,809,000 | 0.16% |
| Partner Investment Management, L.P. | 84,000 | $76,000 | 0.10% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 5,562,000 | $5,013,000 | 0.09% |
| OAKTREE CAPITAL MANAGEMENT LP | 6,000,000 | $5,423,000 | 0.08% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,095,000 | $1,004,000 | 0.04% |
| ACUTA CAPITAL PARTNERS, LLC | 96,000 | $86,000 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,500,000 | $1,352,000,000 | 0.03% |
| AMUNDI ASSET MANAGEMENT US, INC. | 7,305,000 | $6,557,000 | 0.02% |
| Citadel Advisors | 6,230,000 | $5,624,000 | 0.01% |